Several studies utilized genetically manipulated MSCs to deliver and express various anti-tumor agents, including type I interferon (IFN-α and IFN-β), CXCL1, IL-2, IL-12, cytokine deaminase, oncolytic virus, TRAIL and nanoparticles [238–249]. This evidence concerns the gene CXCL1 and neoplasm.